Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer

AIM: To estimate annual societal costs associated with chemotherapy for early breast cancer in the UK. DESIGN: Mixed methods: (a) an incidence-based cost-of-illness model was developed of indirect costs in patients with breast cancer and carers, and estimated from diagnosis through active treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsekar, Krishnali, Howard Wilsher, Stephanie, Sweeting, Anna, Patel, Anita, Fordham, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728345/
https://www.ncbi.nlm.nih.gov/pubmed/33431487
http://dx.doi.org/10.1136/bmjopen-2020-039412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728345/
https://www.ncbi.nlm.nih.gov/pubmed/33431487
http://dx.doi.org/10.1136/bmjopen-2020-039412

Ejemplares similares